Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Apr 10, 2026, 4:00 PM EDT
1.953
-0.027 (-1.36%)
Pre-market: Apr 13, 2026, 8:07 AM EDT

Serina Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
242147334342
Market Cap Growth
-46.86%-56.37%42.45%-22.42%1.70%-27.82%
Enterprise Value
24.6522.4843.5325.5242.0741.41
Last Close Price
1.981.915.0113.7519.7138.93
PE Ratio
--1.00-3.3218.84-15.77-4.81
PS Ratio
187.55158.44842.9310.511256.22291.65
PB Ratio
-4.17----
P/TBV Ratio
4.093.95----
P/FCF Ratio
--1.14-2.75-11.12-7.19-2.69
P/OCF Ratio
--1.15-2.75-13.38-7.19-2.69
EV/Sales Ratio
189.61172.93777.368.091237.25287.59
EV/EBITDA Ratio
--0.95-2.62-8.91-6.15-5.31
EV/EBIT Ratio
--0.94-2.55-8.16-6.03-5.22
EV/FCF Ratio
--1.25-2.54-8.56-7.08-2.65
Net Debt / Equity Ratio
-0.62-0.62----
Net Debt / EBITDA Ratio
0.130.130.222.660.090.08
Net Debt / FCF Ratio
0.170.170.212.560.110.04
Asset Turnover
0.040.040.010.760.050.20
Return on Equity (ROE)
-777.93%-777.93%----
Return on Assets (ROA)
-714.76%-714.76%-301.98%-75.69%-1108.90%-1085.23%
Return on Invested Capital (ROIC)
----156450.00%-48103.40%-4520.23%
Return on Capital Employed (ROCE)
-714.09%-714.09%-301.98%-75.69%-1108.90%-1085.23%
Earnings Yield
-79.71%-99.84%-30.14%5.31%-6.34%-20.78%
FCF Yield
-73.88%-87.46%-36.35%-8.99%-13.90%-37.19%
Buyback Yield / Dilution
-38.47%-38.47%-0.11%-242.70%-99.12%-0.58%
Total Shareholder Return
-38.47%-38.47%-0.11%-242.70%-99.12%-0.58%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q